Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centres

Documenti analoghi

• Strategies for the Induction of Immune Tolerance to Enzyme Replacement Therapy in Mucopolysaccharidosis Type I
  di: Ghosh, Arunabha, et al.
  Pubblicazione: (2019)
• α-L-iduronidase therapy for mucopolysaccharidosis type I
  di: Tolar, Jakub, et al.
  Pubblicazione: (2008)
• Haematopoietic stem cell gene therapy with IL‐1Ra rescues cognitive loss in mucopolysaccharidosis IIIA
  di: Parker, Helen, et al.
  Pubblicazione: (2020)
• Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapy
  di: Pal, Abhijit Ricky, et al.
  Pubblicazione: (2018)
• Hematopoietic stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler’s syndrome after pharmacological enzyme replacement therapy
  di: Saif, Muhammad Ameer, et al.
  Pubblicazione: (2012)